Improving Tumor Oxygenation in Cervical Cancer
Cervical Cancer
About this trial
This is an interventional treatment trial for Cervical Cancer focused on measuring Cervical Cancer
Eligibility Criteria
Inclusion Criteria: The subject will have a malignant tumor of the cervix which is not curable by surgery in which it has been determined the subject is to receive the standard care of treatment of radiation therapy and chemotherapy. The subject must have adequate bone marrow function, renal function, hepatic function and neurologic function. The subject should be free of active infection requiring antibiotics. The subject must have signed the approved informed consent If the subject is of childbearing age, they must have a negative urine pregnancy test with effective contraception The subject must have met pre-entry requirements Physical examination to include pelvic examination, blood counts, assessment of liver and kidney status through blood studies A serum pregnancy test Detectable tumor will be measured. Exclusion Criteria: The subject has not been clinically staged for their cancer The subject has evidence of or is being treated for an active infection The subject cannot perform the appropriate follow-up or complete the study for whatever reason. The subject has not consented to an additional tumor biopsy and MRI after my seven days of treatment with methazolamide The subject has evidence of chronic obstructive pulmonary disease The subject is currently breastfeeding The subject is pregnant The subject takes aspirin chronically The subject has a history of Stevens-Johnson syndrome The subject has not signed the approved informed consent